Nip It in The Bud – Prevent Compulsory Vaccination, Abolish The Measles Protection Act

The German Bundestag petition calling for a review of the Measles Protection Act is online

Anyone who hasn’t been asleep over the past few years will have noticed: the signs point to coercion and state paternalism. Everywhere. But especially in the healthcare sector. The SARS-CoV-2 pandemic was a vast funnel designed to drive the majority of people towards untested and, as we now know, dangerous genetic prevention technologies, which politicians euphemistically sold to us as ‘vaccinations’. The promises were all hollow, not to say outright lies. From Germany’s Merkel’s “The pandemic will be over once we have the vaccine” to Health Ministers’ Spahn and Lauterbach’s “effective and safe”.

During this pandemic, on 10 February 2020, a new Measles Protection Act was enacted, which came into force on 1 March 2020, conveniently at a time when nobody was really paying attention. The draft dates from September 2019, and anyone familiar with ministerial bureaucracy knows that something like this must have been hatched some time beforehand so that it could then be presented to parliament as a draft.

The core of this law is the requirement for nursery school children to provide proof of measles vaccination so that they can attend nursery school or a childcare centre. Immunity to measles can also be demonstrated by antibody titers, i.e., by the fact that a child has already had measles (see). As compulsory schooling takes precedence in Germany, checks may still be carried out and a missing vaccination certificate reported to the health authority, but the authorities are not permitted to prevent the child from attending school. Once compulsory schooling has ended, i.e., for secondary and further education, this may become an issue again.

In effect, therefore, the requirement to provide proof of a measles vaccination amounts to the introduction of a compulsory measles vaccination.

Read more

US Health Bureaucracy: Reorientation towards ‘Autoimmunity’

Admission of guilt by the American health bureaucracy regarding mistakes in coronavirus measures and reorientation towards ‘autoimmunity’

Personnel changes within the US health authorities have resulted in new priorities. Jay Bhattacharya has been director of the National Institutes of Health since 2025, the super-agency that conducts its own research and funds much of the research in the US through large programmes. In addition, Anthony Fauci was replaced by Jeffery Taubenberger as director of the National Institute of Allergy and Infectious Diseases (NIAID) after a brief interim period.

The coronavirus measures were wrong and have damaged the reputation of the NIH and science

In an editorial in Nature Medicine describing the new direction of this institute, Bhattacharya, Taubenberger and their co-author Powers now clearly distance themselves from basically everything that constituted pandemic management in the US and, as a result, almost the entire world [1].

The authors write:

“… many of the recommended policies, including lockdowns, social distancing, school closures, wearing masks and vaccine mandates, lacked robust confirmatory evidence and remain the subject of debate about their overall benefits and unintended consequences. Where enforced, vaccine mandates contributed to decreased public confidence in routine voluntary immunizations. We recognize that much of the American public lost trust in the NIAID, the National Institutes of Health (NIH; of which the NIAID is a part), and in the greater scientific community. As current leaders of the NIH and the NIAID, we acknowledge this breach of trust…”

Let us pause for a moment to consider these words. They describe nothing less than the acknowledgement that the core elements of the so-called ‘pandemic response’, i.e. the political response to the pandemic, were devoid of scientific basis.

Read more

Paul Ehrlich Institute database on side effects of COVID-19 ‘vaccinations’

A workshop report

In my last blog, I discussed the study by the Cologne working group led by Prof. Jan Rybniker. If the findings of immune training were only positive, then we would not be seeing so many serious side effects as a result of these interventions. But we are seeing them, in the side effect database of the Paul Ehrlich Institute (PEI). I had just finished evaluating the first part of the data that the PEI published publicly last summer, when the second part came out. I will therefore have to repeat the evaluation at some point, otherwise it will hardly be of sufficient scientific value. But I will report on my evaluation of the first part here. This is a workshop report; the data has not been published anywhere else.

Read more

The Modified RNA Vaccination Platform is Becoming the Norm for Vaccinations, It Seems…

and this is what needs to be avoided: the approval of Moderna’s mResvia (mRNA1345) proves it

On 15 August 2024, the US Advisory Committee on Immunization Practices (ACIP), issued a recommendation that older people aged 60 and over should receive a dose of a respiratory syncytial virus vaccine. The Centers for Disease Control, the public health authority, recently published this in its weekly report [1]. A new product appears prominently there, the modified RNA prevention, mRNA1345 from Moderna, which is sold under the trade name mResvia.

This is a new gene therapy prevention therapy, referred to as a ‘vaccine’. The corresponding approval study was published in 2023 [2]. I took a closer look at this because I was once again interested in the risk-benefit ratio.

It is important to know that respiratory syncytial viruses (RSVs) are common viruses that are found in every kindergarten, every school class, and every nursing home. Anyone who comes into contact with them and is susceptible will get a cold, cough, hoarseness, maybe even a fever: especially in older people, an infection can develop that takes a more severe course. Probably similar to a corona infection. Basically harmless. Exceptions not ruled out.

Read more

Comirnaty With Up to 500-Fold DNA Contamination Compared to Approval Guarantee

Comirnaty vaccine batches are contaminated with DNA at levels 300- to 500-fold higher than initially approved

Pfizer’s modified RNA injections, along with those from other manufacturers, pose several issues. A significant concern is the contamination with DNA. This deoxyribonucleic acid (DNA) originates from genetically modified bacterial strains engineered to produce the target RNA of the spike protein, intended to trigger the immune response. The DNA, therefore, is a byproduct that should be thoroughly removed. Kevin McKernan identified and publicized this over a year ago. Recently, Professor König from Magdeburg has demonstrated that this issue is also present in Germany, even in standard vaccine batches provided by Pfizer [1]. Professor König is a virologist at the University of Leipzig and conducted these investigations in her private laboratory in Magdeburg. The findings (refer to the figure below corresponding to Fig. 2 from the original publication) show that the DNA content in these batches exceeds permissible levels by a factor of 300 to 500:

Read more